Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program

BACKGROUND: Randomized phase III trials are ongoing to investigate the efficacy of nivolumab in malignant pleural mesothelioma (MPM), but real-world data are still scarce. In this real-world study, we investigated the clinical outcomes of nivolumab treatment in pre-treated MPM patients. METHODS: Dat...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transl Lung Cancer Res
Autori principali: Cantini, Luca, Belderbos, Robert A., Gooijer, Cornedine J., Dumoulin, Daphne W., Cornelissen, Robin, Baart, Sara, Burgers, Jacobus A., Baas, Paul, Aerts, Joachim G. J. V.
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481613/
https://ncbi.nlm.nih.gov/pubmed/32953495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-686
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi